Attached files
| file | filename |
|---|---|
| 10-K/A - FORM 10-K/A - PLUS THERAPEUTICS, INC. | form10ka.htm |
| EX-31.1 - EXHIBIT 31.1 - PLUS THERAPEUTICS, INC. | ex31_1.htm |
| EX-32.1 - EXHIBIT 32.1 - PLUS THERAPEUTICS, INC. | ex32_1.htm |
EXHIBIT 31.2
Certification of Principal Financial Officer Pursuant to
Securities Exchange Act Rule 13a-14(a)
As Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
Securities Exchange Act Rule 13a-14(a)
As Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Tiago M. Girão, certify that:
1. I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Cytori Therapeutics, Inc.;
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
|
Date: March 24, 2016
|
|
|
/s/ Tiago M. Girão
|
|
|
Tiago M. Girão,
|
|
|
VP of Finance and Chief Financial Officer
|
|